Cancer Family
Esophageal Neoplasm
CI-CAN-00000174Explore in graph →
Non-malignant555 active trials6 approved drugs12 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000174Explore in graph →
Clinical trials
2,208 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00093652 | Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer | terminated | Phase 1 / Phase 2 | — | Roswell Park Cancer InstituteOTHER | 1 | Oct 6, 2015 | clinicaltrials |
| NCT00258323 | Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer | completed | Phase 2 | 80 | Case Comprehensive Cancer CenterOTHER | 1 | Sep 30, 2015 | clinicaltrials |
| NCT00397384 | Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer | completed | Phase 1 | 43 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2015 | clinicaltrials |
| NCT01871636 | ESD Versus EMR for Treatment of Early Barrett's Adenocarcinoma | completed | N/A | 40 | Evangelisches Krankenhaus DüsseldorfOTHER | 1 | Sep 9, 2015 | clinicaltrials |
| NCT02461043 | Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Adjuvant Chemotherapy in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell Carcinoma | unknown | Phase 3 | 386 | Chinese Academy of Medical SciencesOTHER | 1 | Sep 1, 2015 | clinicaltrials |
| NCT02319187 | Irinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Cancer: ESWN 01 Trial | unknown | Phase 3 | 240 | Chinese Academy of Medical SciencesOTHER | 1 | Aug 3, 2015 | clinicaltrials |
| NCT00442507 | Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction(OSI3650) | terminated | Phase 2 | 6 | Washington University School of MedicineOTHER | 1 | Jul 24, 2015 | clinicaltrials |
| NCT02490735 | CIK in Treating Patients With Esophageal Cancer | not yet recruiting | Phase 2 | 2,000 | The First People's Hospital of ChangzhouOTHER | 0 | Jul 7, 2015 | clinicaltrials |
| NCT00578071 | Phase I/II Study of Panitumumab, Capecitabine and Oxaliplatin w EBRT for Esophageal Cancer(POXX) | completed | Phase 1 / Phase 2 | 29 | Brian CzitoOTHER | 1 | Jul 2, 2015 | clinicaltrials |
| NCT02464930 | Evaluation of MicroRNA Expression in Blood and Cytology for Detecting Barrett's Esophagus and Associated Neoplasia | unknown | — | 220 | Midwest Biomedical ResearchOTHER | 1 | Jun 8, 2015 | clinicaltrials |
| NCT01301495 | Prospective Evaluation of a New Covered Metal Stent for Malignant Lesions of the Esophagus | withdrawn | Phase 2 | 0 | Weill Medical College of Cornell UniversityOTHER | 1 | Jun 3, 2015 | clinicaltrials |
| NCT02448953 | Two-field Versus Three-field Lymphadenectomy in Thoracic Esophageal Carcinoma Without Cervical Lymph Node Involvement | unknown | N/A | 786 | Chinese Academy of Medical SciencesOTHER | 1 | May 20, 2015 | clinicaltrials |
| NCT02448966 | Traditional Three-incision Esophagectomy Versus Minimally Invasive Thorascopic and Laparoscopic Esophagectomy | unknown | — | 1,000 | Chinese Academy of Medical SciencesOTHER | 1 | May 20, 2015 | clinicaltrials |
| NCT02448979 | Esophagectomy in Middle and Lower Thoracic Esophageal Cancer Patients Through Left Versus Right Transthoracic Approach | unknown | Phase 3 | 800 | Chinese Academy of Medical SciencesOTHER | 1 | May 20, 2015 | clinicaltrials |
| NCT00130689 | Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer | completed | Phase 2 | 43 | Dana-Farber Cancer InstituteOTHER | 1 | May 14, 2015 | clinicaltrials |
| NCT00019110 | Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00019435 | LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00019825 | Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT02309619 | Lifting of Gastric Tube Through Trans-substernal Versus Trans-esophageal Bed Path in MIE | unknown | N/A | 60 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityOTHER | 1 | Apr 16, 2015 | clinicaltrials |
| NCT02418052 | Effect of Neck Flexion on Esophagogastric Anastomotic Leakage After MIE | unknown | N/A | 60 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityOTHER | 1 | Apr 16, 2015 | clinicaltrials |
| NCT02133612 | Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma | completed | Phase 2 | 43 | Chinese Academy of Medical SciencesOTHER | 1 | Apr 14, 2015 | clinicaltrials |
| NCT02023541 | Proton Beam Therapy to Treat Esophageal Cancer | terminated | Phase 1 | 3 | Washington University School of MedicineOTHER | 1 | Apr 7, 2015 | clinicaltrials |
| NCT02409849 | Octreotide LAR as Maintenance Treatment for Patients With NEC | unknown | Phase 2 | 92 | Peking UniversityOTHER | 1 | Apr 7, 2015 | clinicaltrials |
| NCT02403050 | Feasibility Study of Fiducial Markers in Oesophageal Cancer | unknown | — | 40 | NHS Greater Glasgow and ClydeOTHER | 1 | Mar 31, 2015 | clinicaltrials |
| NCT00735345 | Chemotherapy Induction and Chemoradiotherapy in Patients With Esophageal Carcinoma | terminated | Phase 2 | 50 | Arbeitsgemeinschaft medikamentoese TumortherapieOTHER | 1 | Mar 9, 2015 | clinicaltrials |
| NCT02033538 | Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Squamous Cell Carcinoma of Esophagus | withdrawn | Phase 2 | 0 | Zhejiang UniversityOTHER | 1 | Mar 5, 2015 | clinicaltrials |
| NCT02034968 | Nimotuzumab Plus Nab-paclitaxel and Cisplatin in Treating Patients With Advanced Esophageal Carcinoma | withdrawn | Phase 2 | 0 | Zhejiang UniversityOTHER | 1 | Mar 5, 2015 | clinicaltrials |
| NCT02041819 | Neoadjuvant Chemotherapy of Nimotuzumab Plus Nab-Paclitaxel in Squamous Cell Carcinoma of Esophagus | withdrawn | Phase 2 | 0 | Zhejiang UniversityOTHER | 1 | Mar 5, 2015 | clinicaltrials |
| NCT01981876 | Study of Esophageal Squamous Dysplasia Prevalence at Tenwek Hospital(STEP) | completed | — | 305 | Tenwek HospitalOTHER | 1 | Feb 27, 2015 | clinicaltrials |
| NCT00447330 | Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma(XAGastric) | completed | Phase 2 | 60 | Duke UniversityOTHER | 1 | Feb 13, 2015 | clinicaltrials |
| NCT00909350 | Micro-RNA (miR) Expression in Upper Gastrointestinal Mucosal Tissue | completed | — | 10 | Mayo ClinicOTHER | 1 | Feb 12, 2015 | clinicaltrials |
| NCT02011594 | Phase II Study of Maintenance Treatment of Nimotuzumab for Advanced Esophageal Carcinoma | withdrawn | Phase 2 | 0 | Zhejiang UniversityOTHER | 1 | Feb 12, 2015 | clinicaltrials |
| NCT00525915 | Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma | completed | Phase 2 | 126 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 9, 2015 | clinicaltrials |
| NCT01766349 | Effect of CCRT on Respiratory Performance and Functional Capacity in Esophagus Cancer Patients | completed | — | 100 | Far Eastern Memorial HospitalOTHER | 1 | Feb 5, 2015 | clinicaltrials |
| NCT02355249 | Traditional Three Incisions vs Minimally Invasive Thoracol-laparoscopic Esophagectomy for Esophageal Cancer | unknown | Phase 3 | 648 | Chinese Academy of Medical SciencesOTHER | 1 | Feb 4, 2015 | clinicaltrials |
| NCT01760070 | Comparison of O-type Hybrid Knife and IT Knife in ESD | completed | N/A | 78 | Xijing Hospital of Digestive DiseasesOTHER | 1 | Jan 26, 2015 | clinicaltrials |
| NCT01995084 | In Vivo Assessment of Hypoxia in Gastro-intestinal Cancer Using 18F-HX4-PET: an Optimization and Reproducibility Study(HYPE) | completed | N/A | 32 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Jan 14, 2015 | clinicaltrials |
| NCT01158287 | Sorafenib. ICORG 06-41, V4 | completed | Phase 2 | 54 | Cancer Trials IrelandNETWORK | 1 | Dec 31, 2014 | clinicaltrials |
| NCT01156831 | PET-CT Based Radiotherapy in Esophageal Cancer Patients | completed | — | 115 | Maastricht Radiation OncologyOTHER | 1 | Dec 8, 2014 | clinicaltrials |
| NCT00716157 | Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation | completed | — | 40 | Thomas Jefferson UniversityOTHER | 1 | Dec 5, 2014 | clinicaltrials |
| NCT01870817 | Home Jejunostomy Feeding Following Esophagectomy/Gastrectomy | completed | N/A | 54 | University Hospitals, LeicesterOTHER | 1 | Dec 4, 2014 | clinicaltrials |
| NCT00374985 | Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-oesophageal Junction | completed | Phase 1 / Phase 2 | 25 | Johannes Gutenberg University MainzOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT01698190 | Comparing the Efficacy of Endoscopic FNA vs FNB in Diagnosing Solid Gastrointestinal Lesions | unknown | N/A | 400 | Stony Brook UniversityOTHER | 1 | Nov 19, 2014 | clinicaltrials |
| NCT01770275 | UICC Classification of Esophageal Cancer | completed | — | 605 | Universitätsklinikum Hamburg-EppendorfOTHER | 1 | Nov 18, 2014 | clinicaltrials |
| NCT01858805 | Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer | completed | — | 123 | Universitätsklinikum Hamburg-EppendorfOTHER | 1 | Nov 18, 2014 | clinicaltrials |
| NCT00153881 | Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal Cancer | completed | Phase 1 | 44 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Nov 13, 2014 | clinicaltrials |
| NCT00165490 | Combination Chemotherapy, Radiation Therapy and Surgery for Esophageal Cancer | completed | Phase 2 | 19 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 10, 2014 | clinicaltrials |
| NCT01246960 | A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer | completed | Phase 2 | 168 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 8, 2014 | clinicaltrials |
| NCT00042510 | Safety and Efficacy of G17DT Immunogen in the Treatment of Gastric and Gastroesophageal Cancer | completed | Phase 2 | 103 | Cancer Advances Inc.INDUSTRY | 0 | Aug 28, 2014 | clinicaltrials |
| NCT00867477 | PMRR-NO: Pulmonary Metabolic Radiation Response Versus Exhaled Nitric Oxide | completed | Phase 2 | 163 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 28, 2014 | clinicaltrials |
Data updated 24 days agoSource updated Oct 6, 2015source: clinicaltrials